Genus Capital Management »

Edwards Lifesciences shares owned by Genus Capital Management

Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Genus Capital Management from 13F filings

Historical chart of Genus Capital Management investment in Edwards Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Edwards Lifesciences held by Genus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edwards Lifesciences by Genus Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 120k 95.56
2023-12-31 $4.9M 65k 76.25

More positions owned by Genus Capital Management

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Merck & Co (MRK)
Acuity Brands (AYI)
Ishares Tr Core Us Aggbd Et (AGG)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Ishares Tr Us Treas Bd Etf (GOVT)
Canadian Natl Ry (CNI)
Sprouts Fmrs Mkt (SFM)
Celestica Sub Vtg Shs (CLS)
Microsoft Corporation (MSFT)
Edwards Lifesciences (EW)
Kinross Gold Corp (KGC)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Genus Capital Management

Top funds holding Edwards Lifesciences

BlackRock
Vanguard Group
Alliancebernstein
Bank of New York Mellon
Wellington Management Company
Brown Advisory Holdings Incorporated
Geode Capital Management
Jpmorgan Chase & Co
FMR
Fisher Investments
T. Rowe Price Associates
Morgan Stanley
Sands Capital Management
Northern Trust
Amundi

View all funds holding Edwards Lifesciences